Twin reversed arterial perfusion: fetoscopic laser coagulation of placental anastomoses or the umbilical cord.
Standard
Twin reversed arterial perfusion: fetoscopic laser coagulation of placental anastomoses or the umbilical cord. / Hecher, Kurt; Lewi, L; Gratacos, E; Huber, Agnes; Ville, Y; Deprest, J.
In: ULTRASOUND OBST GYN, Vol. 28, No. 5, 5, 2006, p. 688-691.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Twin reversed arterial perfusion: fetoscopic laser coagulation of placental anastomoses or the umbilical cord.
AU - Hecher, Kurt
AU - Lewi, L
AU - Gratacos, E
AU - Huber, Agnes
AU - Ville, Y
AU - Deprest, J
PY - 2006
Y1 - 2006
N2 - OBJECTIVE: To assess the feasibility and outcome of fetoscopic laser coagulation in pregnancies with twin reversed arterial perfusion (TRAP) sequence. METHODS: In a prospective multicenter study, percutaneous fetoscopic laser coagulation of placental anastomoses (n = 18) or the umbilical cord of the acardiac twin (n = 42) was performed in 60 consecutive pregnancies at a median gestational age of 18.3 (range, 14.3-24.7) weeks under local or locoregional anesthesia. RESULTS: Vascular coagulation with arrest of blood flow was achieved in 82% (49/60) of cases by laser alone and in a further 15% (9/60) by laser coagulation in combination with bipolar forceps. The overall survival rate of the pump twin was 80% (48/60). Median gestational age at delivery was 37.4 (range, 23.7-41.4) weeks and the median interval between the procedure and delivery was 18.2 (range, 1.1-25.7) weeks. Median birth weight was 2720 (range, 540-3840) g. Preterm premature rupture of membranes before 34 weeks' gestation occurred in 18% (11/60) at a median of 62 (range, 1-102) days after the procedure. However, only two (3%) women delivered within 28 days of the procedure. CONCLUSIONS: Fetoscopic laser coagulation of placental vascular anastomoses or the umbilical cord of the acardiac twin is an effective treatment of TRAP sequence, with a survival rate of 80%, and 67% of pregnancies with surviving pump twins going beyond 36 weeks' gestation without further complications.
AB - OBJECTIVE: To assess the feasibility and outcome of fetoscopic laser coagulation in pregnancies with twin reversed arterial perfusion (TRAP) sequence. METHODS: In a prospective multicenter study, percutaneous fetoscopic laser coagulation of placental anastomoses (n = 18) or the umbilical cord of the acardiac twin (n = 42) was performed in 60 consecutive pregnancies at a median gestational age of 18.3 (range, 14.3-24.7) weeks under local or locoregional anesthesia. RESULTS: Vascular coagulation with arrest of blood flow was achieved in 82% (49/60) of cases by laser alone and in a further 15% (9/60) by laser coagulation in combination with bipolar forceps. The overall survival rate of the pump twin was 80% (48/60). Median gestational age at delivery was 37.4 (range, 23.7-41.4) weeks and the median interval between the procedure and delivery was 18.2 (range, 1.1-25.7) weeks. Median birth weight was 2720 (range, 540-3840) g. Preterm premature rupture of membranes before 34 weeks' gestation occurred in 18% (11/60) at a median of 62 (range, 1-102) days after the procedure. However, only two (3%) women delivered within 28 days of the procedure. CONCLUSIONS: Fetoscopic laser coagulation of placental vascular anastomoses or the umbilical cord of the acardiac twin is an effective treatment of TRAP sequence, with a survival rate of 80%, and 67% of pregnancies with surviving pump twins going beyond 36 weeks' gestation without further complications.
M3 - SCORING: Zeitschriftenaufsatz
VL - 28
SP - 688
EP - 691
JO - ULTRASOUND OBST GYN
JF - ULTRASOUND OBST GYN
SN - 0960-7692
IS - 5
M1 - 5
ER -
